Respiratory test portfolio designed to maximise sample throughput and ensure clinically relevant turn around times for critical patient results.
Dual-target, single-well, multiplex qPCR assay for the detection of COVID-19 causative coronavirus (SARS-CoV-2). Compatible with other respiratory virus tests and PlexPrep™ automation for a simple scalable solution.
Two-well, multiplex qPCR assay for the detection of Influenza A, Influenza B, Rhinoviruses (A & B), Respiratory Syncytial Viruses (A & B), Human metapneumovirus, Adenoviruses, and Human parainfluenza viruses 1, 2, 3 and 4.
“The workflow advantages afforded by PlexPCR® RespiVirus means more patient results can be reported over the course of a workday compared to standard technologies.”